Investment Research & Advisory Group, Inc. Organon & Co. Transaction History

Investment Research & Advisory Group, Inc.

$331 Million
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$10.95 - $17.32 $1,029 - $1,628	-94 Reduced 98.95%	1 $0
Q3 2023 Oct 19, 2023	SELL	$16.59 - $23.77 $1,824 - $2,614	-110 Reduced 53.66%	95 $1,000
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $1,187 - $1,535	-39 Reduced 15.98%	205 $7,000
Q4 2021 Jan 19, 2022	BUY	$28.67 - $37.13 $6,995 - $9,059	244 New	244 $7,000

Others Institutions Holding OGN

# of Institutions

790

Shares Held

201M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$535 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$495 Million
0.01% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.2M
Shares

$183 Million
0.41% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$160 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$147 Million
0.01% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Research & Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Investment Research & Advisory Group, Inc. with notifications on news.

Account